Jasper Therapeutics To Implement 1-for-30 Reverse Stock Split

(RTTNews) - asper Therapeutics, Inc. (JSPR), a clinical-stage biotechnology company focused on therapies for immune-mediated diseases, announced that it will effect a 1-for-30 reverse split of its issued and outstanding common stock, effective at 12:01 a.m. Eastern Time on Novemb